Financial Architects (New Jersey)’s Agios Pharmaceuticals AGIO Stock Holding History

Financial Architects (New Jersey)’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$42K	–	1557
2016 Q4	$42K	Hold	1,000	–	–	0.01%	608
2016 Q3	$53K	Sell	1,000 -14	-1%	-$610	0.01%	560
2016 Q2	$42K	Sell	1,014 -400	-28%	-$19.8K	0.01%	575
2016 Q1	$57K	Buy	+1,414	New	+$60.5K	0.02%	372
2015 Q3	–	Sell	-2,014	Closed	-$224K	–	224
2015 Q2	$224K	Hold	2,014	–	–	0.08%	180
2015 Q1	$190K	Buy	2,014 +14	+0.7%	+$1.57K	0.07%	197
2014 Q4	$224K	Buy	+2,000	New	+$179K	0.1%	156

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Financial Architects (New Jersey)'s AGIO Position: Q1 2017 in Review

Financial Architects (New Jersey) sold out of Agios Pharmaceuticals (AGIO) in Q1 2017, closing a stake of 1,000 shares — an estimated $42K sold.

Financial Architects (New Jersey) first reported a position in AGIO in Q4 2014 and held it in 7 quarters. The position peaked at $224K in Q2 2015. 156 funds tracked by Wall St. Rank hold AGIO as of Q1 2017.

Financial Architects (New Jersey) reported no remaining Agios Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Financial Architects (New Jersey) sold 1,000 Agios Pharmaceuticals shares in Q1 2017, an estimated $42K.
Financial Architects (New Jersey) first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 7 quarters.
Financial Architects (New Jersey)'s Agios Pharmaceuticals position peaked at $224K in Q2 2015.
156 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2017, filed 26 Apr 2017.